Showing results (671-680 of 944) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|June 12, 2024
An Ethnographic Study of Patient Life Experience in Early-Stage Parkinson's Disease in the United States and GermanyTodd Carmody, Rebekah Park, Elisabeth Bennett, et al.
Neurology and Therapy|May 31, 2024
Photophobia and Visual Triggers in Vestibular MigraineXiaodong Zou, Jiahui He, Mengting Zhou, et al.
Neurology and Therapy|May 30, 2024
Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc AnalysisGilbert J L'Italien, Evangelos K Oikonomou, Rohan Khera, et al.
Neurology and Therapy|June 8, 2024
Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS StudySimona Lattanzi, Federica Ranzato, Carlo Di Bonaventura, et al.
Neurology and Therapy|June 24, 2024
Neuroendoscopic Parafascicular Evacuation of Spontaneous Intracerebral Hemorrhage (NESICH Technique): A Multicenter Technical Experience with Preliminary FindingsLong Wang, Xiaodong Li, Zhongyong Deng, et al.
Neurology and Therapy|June 14, 2024
Subcutaneous Levodopa: A New Engine for the Vintage MoleculeKarolina Poplawska-Domaszewicz, Lucia Batzu, Cristian Falup-Pecurariu, et al.
Neurology and Therapy|May 28, 2024
Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-Injector ZENEO® in Healthy AdultsOlivier Lacombe, Yannick Pletan, Jean-Marie Grouin, et al.
Neurology and Therapy|May 15, 2024
Male Reproduction in Spinal Muscular Atrophy (SMA) and the Potential Impact of Oral Survival of Motor Neuron 2 (SMN2) Pre-mRNA Splicing ModifiersNatan Bar-Chama, Bakri Elsheikh, Channa Hewamadduma, et al.
Neurology and Therapy|November 22, 2025
A Randomised, Double-Blind Study Comparing the Gastrointestinal Tolerability of Tegomil Fumarate Versus Dimethyl Fumarate in Healthy VolunteersMarlene Fonseca, Gabriel Bauzà Valverde, Abdelkarim Bendarraz, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Pageof 95